Preparatory dispensation systems and methods

• US 20090326516A1
• Filed: 06/30/2008
• Published: 12/31/2009
• Est. Priority Date: 06/30/2008
• Status: Abandoned Application

• Current Assignee: Searete LLC (Intellectual Ventures LLC)
• Original Assignee: Searete LLC (Intellectual Ventures LLC)
• Inventors: Ishikawa, Muriel Y., Boyden, Edward S., Wood, Lowell L. JR., Rivet, Dennis J., Hyde, Roderick A., Sweeney, Elizabeth A., Wood, Victoria Y.H., Bangera, Mahalaxmi Gita, Leuthardt, Eric C.
• Application Number:
  US12/217,129
• Publication Number:
  US 20090326516A1
• Time in Patent Office: Days
• US Class Current: 604/890.1
• CPC Class Codes: A61M 2205/3553 remote, e.g. between patient's home and doctor's office
• CPC Class Codes: A61M 2205/3561 local, e.g. within room or hospital
• CPC Class Codes: A61M 2205/3592 using telemetric means, e.g. radio or optical transmission
• CPC Class Codes: A61M 31/002 Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time artificial gland structures or devices A61F2/022; intra-uterine contraceptive devices A61F6/14; tampons for introducing into the vagina A61F13/20, A61L15/00; suppositories or bougies for intra-vaginal or intra-uterine application A61K9/02; physical forms of medicinal preparations for sustained or differential drug release A61K9/20, A61K9/50
• CPC Class Codes: A61M 5/1723 using feedback of body parameters, e.g. blood-sugar, pressure measurement of body parameters A61B5/00
• CPC Class Codes: G16H 20/13 delivered from dispensers
• CPC Class Codes: G16H 20/70 relating to mental therapies, e.g. psychological therapy or autogenous training
• CPC Class Codes: G16H 40/67 for remote operation

Abstract

Methods and systems are described for receiving wireless control signal content into a module containing one or more active ingredients and causing one or more dispensations from the module according to a programmatic dispensation profile partly dependent on the wireless control signal content and partly dependent on an attribute of the module; or for obtaining data indicating a future event time intended by an individual, and causing a bioactive material administration to the individual in response to the data to occur about or before the future event time.

Claims

1. A treatment system comprising:

circuitry for receiving wireless control signal content into a module containing one or more active ingredients; and

circuitry for causing one or more dispensations from the module according to a programmatic dispensation profile partly dependent on the wireless control signal content and partly dependent on an attribute of the module.

2. The treatment system of claim 1, further comprising:

a conduit operable to bear at least one of the one or more active ingredients out of the module.

3. The treatment system of claim 1, further comprising:

circuitry for configuring at least one dosage of the programmatic dispensation profile.

4. The treatment system of claim 1, further comprising:

the module, containing at least some psychoactive material of the one or more active ingredients.

5. The treatment system of claim 1, further comprising:

the module, configured as an ingestible device operable to perform at least one of the one or more dispensations according to the programmatic dispensation profile.

6. The treatment system of claim 1, further comprising:

circuitry for causing one or more dispensations from another module according to the programmatic dispensation profile.

7. The treatment system of claim 1 in which the circuitry for causing one or more dispensations from the module according to a programmatic dispensation profile partly dependent on the wireless control signal content and partly dependent on an attribute of the module comprises:

circuitry for enabling a release of one or more of a narcotic or a sedative.

8. The treatment system of claim 1 in which the circuitry for causing one or more dispensations from the module according to a programmatic dispensation profile partly dependent on the wireless control signal content and partly dependent on an attribute of the module comprises:

circuitry for causing an injection of at least one of the one or more active ingredients into a body lumen.

9. The treatment system of claim 1 in which the circuitry for causing one or more dispensations from the module according to a programmatic dispensation profile partly dependent on the wireless control signal content and partly dependent on an attribute of the module comprises:

circuitry for enabling a release of one or more of a methylxanthine or a sympathomimetic amine.

10. The treatment system of claim 1 in which the circuitry for causing one or more dispensations from the module according to a programmatic dispensation profile partly dependent on the wireless control signal content and partly dependent on an attribute of the module comprises:

circuitry for causing the module to dispense a stimulant.

11. The treatment system of claim 1 in which the circuitry for causing one or more dispensations from the module according to a programmatic dispensation profile partly dependent on the wireless control signal content and partly dependent on an attribute of the module comprises:

circuitry for configuring a dispensation-initiation-time indicator in response to a type of the module.

12. The treatment system of claim 1 in which the circuitry for causing one or more dispensations from the module according to a programmatic dispensation profile partly dependent on the wireless control signal content and partly dependent on an attribute of the module comprises:

circuitry for scheduling a first future component of the programmatic dispensation profile and a second future component of the programmatic dispensation profile.

13. The treatment system of claim 1 in which the circuitry for causing one or more dispensations from the module according to a programmatic dispensation profile partly dependent on the wireless control signal content and partly dependent on an attribute of the module comprises:

circuitry for causing at least one of the one or more active ingredients to be absorbed via a mucous membrane.

14. The treatment system of claim 1 in which the circuitry for causing one or more dispensations from the module according to a programmatic dispensation profile partly dependent on the wireless control signal content and partly dependent on an attribute of the module comprises:

circuitry for triggering a delivery of at least a first one of the one or more active ingredients from the module at an earlier time; and

circuitry for triggering a delivery of at least a second one of the one or more active ingredients from the module at a later time.

15. The treatment system of claim 1 in which the circuitry for causing one or more dispensations from the module according to a programmatic dispensation profile partly dependent on the wireless control signal content and partly dependent on an attribute of the module comprises:

circuitry for controlling at least one of the one or more dispensations based on whether a wireless control signal contains a delay time indicator, on when the wireless control signal arrives, and on a state of the module.

16. The treatment system of claim 1 in which the circuitry for causing one or more dispensations from the module according to a programmatic dispensation profile partly dependent on the wireless control signal content and partly dependent on an attribute of the module comprises:

circuitry for scheduling at least one of the one or more dispensations to be complete by a time identified by user input.

17. The treatment system of claim 1 in which the circuitry for receiving wireless control signal content into a module containing one or more active ingredients comprises:

circuitry for receiving a time-indicative value of the wireless control signal content.

18. The treatment system of claim 1 in which the circuitry for receiving wireless control signal content into a module containing one or more active ingredients comprises:

circuitry for receiving the wireless control signal content with the module adjacent tissue of a subject from a device outside the subject.

19. The treatment system of claim 1 in which the circuitry for receiving wireless control signal content into a module containing one or more active ingredients comprises:

circuitry for causing the one or more active ingredients to include at least one active ingredient selected from a group consisting of a psychoactive agent, a vasodilator, and a vasoconstrictor.

50. The treatment system of claim 1, in which the circuitry for causing one or more dispensations from the module according to a programmatic dispensation profile partly dependent on the wireless control signal content and partly dependent on an attribute of the module comprises:

circuitry for controlling at least one of the one or more dispensations based on whether a wireless control signal contains a delay time indicator, on when the wireless control signal arrives, on a state of the module, and on a type of the module;

circuitry for triggering a delivery of at least a first one of the one or more active ingredients from the module at an earlier time, the first one of the one or more active ingredients including one or more of a narcotic or a sedative; and

circuitry for triggering a delivery of at least a stimulant of the one or more active ingredients from the module to be complete by a later time identified by user input.

51. The treatment system of claim 1, further comprising:

the module, containing at least some psychoactive material of the one or more active ingredients and configured as an ingestible device operable to perform at least one of the one or more dispensations according to the programmatic dispensation profile;

circuitry for configuring at least one dosage of the programmatic dispensation profile;

circuitry for causing one or more dispensations from another module according to the programmatic dispensation profile; and

a conduit operable to bear at least one of the one or more active ingredients out of the module.

20. A treatment system comprising:

means for receiving wireless control signal content into a module containing one or more active ingredients; and

means for causing one or more dispensations from the module according to a programmatic dispensation profile partly dependent on the wireless control signal content and partly dependent on an attribute of the module.

21. The treatment system of claim 20, further comprising:

means for causing one or more dispensations from another module according to the programmatic dispensation profile.

22. The treatment system of claim 20 in which the means for causing one or more dispensations from the module according to a programmatic dispensation profile partly dependent on the wireless control signal content and partly dependent on an attribute of the module comprises:

means for enabling a release of one or more of a narcotic or a sedative.

23-34. -34. (canceled)

35. A treatment method comprising:

receiving wireless control signal content into a module containing one or more active ingredients; and

causing one or more dispensations from the module according to a programmatic dispensation profile partly dependent on the wireless control signal content and partly dependent on an attribute of the module.

41. The treatment method of claim 35 in which the causing one or more dispensations from the module according to a programmatic dispensation profile partly dependent on the wireless control signal content and partly dependent on an attribute of the module comprises:

configuring a dispensation-initiation-time indicator in response to a type of the module.

42. The treatment method of claim 35 in which the causing one or more dispensations from the module according to a programmatic dispensation profile partly dependent on the wireless control signal content and partly dependent on an attribute of the module comprises:

scheduling a first future component of the programmatic dispensation profile and a second future component of the programmatic dispensation profile.

44. The treatment method of claim 35 in which the causing one or more dispensations from the module according to a programmatic dispensation profile partly dependent on the wireless control signal content and partly dependent on an attribute of the module comprises:

triggering a delivery of at least a first one of the one or more active ingredients from the module at an earlier time; and

triggering a delivery of at least a second one of the one or more active ingredients from the module at a later time.

46. The treatment method of claim 35 in which the causing one or more dispensations from the module according to a programmatic dispensation profile partly dependent on the wireless control signal content and partly dependent on an attribute of the module comprises:

scheduling at least one of the one or more dispensations to be complete by a time identified by user input.

48. The treatment method of claim 35 in which the receiving wireless control signal content into a module containing one or more active ingredients comprises:

receiving the wireless control signal content with the module adjacent tissue of a subject from a device outside the subject.

36-40. -40. (canceled)

43. (canceled)

45. (canceled)

47. (canceled)

49. (canceled)